The following is a summary of “A clot waveform analysis-based system for differential diagnosis of prolonged activated ...

The Phase I trial of the company’s SRSD107 siRNA therapy found the treatment to be safe and well tolerated as part of its ...

The most common methods for monitoring UFH are the activated partial thromboplastin time (aPTT) and antifactor Xa heparin assay (anti-Xa HA), but both present challenges, and the optimal method to ...